Fraser is an Associate Director for Business Development and Operations at Pangea Bio and Kanna Health. He engages cross-functionally to deliver on our strategic priorities, and has a role in R&D, finance, and investor relations.
Fraser was previously an Associate Consultant at L.E.K. Consulting, working in the life sciences practice. He was engaged in a range of projects including buy-side and sell-side commercial due diligence, commercial strategy, and go-to-market strategy, for large and small pharma players and adjacent industry areas within the life sciences sector, including life science focused VCs and PE houses.
Fraser studied Molecular and Cellular Biochemistry at Oxford University, specialised in plant metabolism.